Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04308148 · ClinicalTrials.gov registry record
Does Medical Cannabis Reduce Opioid Use in Adults With Pain
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- 217
- Enrollment target
NCT04308148 is a clinical trial that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 217 participants.
The verdict
NCT04308148 has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
Study Summary
The study will examine how medical cannabis use affects opioid analgesic use. This landmark study will be among the first to examine the effect of medical cannabis with different THC/CBD (Tetrahydrocannibinol/Cannabidiol) content on opioid use as well as adverse events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2020-10-06 |
| Est. Completion | 2024-03-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04308148
The ClinicalTrials.gov registry entry for NCT04308148 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04308148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04308148 about?
NCT04308148 is a clinical study titled "Does Medical Cannabis Reduce Opioid Use in Adults With Pain". The study will examine how medical cannabis use affects opioid analgesic use. This landmark study will be among the first to examine the effect of medical cannabis with different THC/CBD (Tetrahydrocannibinol/Cannabidiol) content on opioid use as well as adverse events.
What is the current status of trial NCT04308148?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2020-10-06. Estimated completion is 2024-03-13.
Who is sponsoring clinical trial NCT04308148?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.